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Abstract: Cardiac mesenchymal stem cells (C-MSC) play a key role in maintaining normal cardiac
function under physiological and pathological conditions. Glycolysis and mitochondrial oxidative
phosphorylation predominately account for energy production in C-MSC. Dicer, a ribonuclease III
endoribonuclease, plays a critical role in the control of microRNA maturation in C-MSC, but its role in
regulating C-MSC energy metabolism is largely unknown. In this study, we found that Dicer knockout
led to concurrent increase in both cell proliferation and apoptosis in C-MSC compared to Dicer
floxed C-MSC. We analyzed mitochondrial oxidative phosphorylation by quantifying cellular oxygen
consumption rate (OCR), and glycolysis by quantifying the extracellular acidification rate (ECAR),
in C-MSC with/without Dicer gene deletion. Dicer gene deletion significantly reduced mitochondrial
oxidative phosphorylation while increasing glycolysis in C-MSC. Additionally, Dicer gene deletion
selectively reduced the expression of β-oxidation genes without affecting the expression of genes
involved in the tricarboxylic acid (TCA) cycle or electron transport chain (ETC). Finally, Dicer gene
deletion reduced the copy number of mitochondrially encoded 1,4-Dihydronicotinamide adenine
dinucleotide (NADH): ubiquinone oxidoreductase core subunit 6 (MT-ND6), a mitochondrial-encoded
gene, in C-MSC. In conclusion, Dicer gene deletion induced a metabolic shift from oxidative metabolism
to aerobic glycolysis in C-MSC, suggesting that Dicer functions as a metabolic switch in C-MSC,
which in turn may regulate proliferation and environmental adaptation.
Keywords: dicer; mitochondrial oxidative metabolism; cardiac mesenchymal stem cells (C-MSC);
aerobic glycolysis; β-oxidation; Warburg effect
1. Introduction
Cardiovascular diseases are the leading cause of morbidity and mortality worldwide [1]. In patients
with heart failure, disorders of substrate utilization and intermediate metabolism, energy deficiency,
and oxidative stress underlie the basis of systolic dysfunction and disease progression [2]. Mitochondria
control many biological processes, most importantly, aerobic metabolism to generate ATP, a process
known as oxidative phosphorylation (OXPHOS). In the normal adult heart, about 70% of ATP
production is derived from fatty acid oxidation [3]. To sustain sufficient energy production required to
support the continuous mechanical workload, however, the heart utilizes diverse energy substrates,
including glucose and amino acids [4]. Fatty acid oxidation is a complex biological process involving
including mitochondrial β-oxidation, tricarboxylic acid (TCA) cycle activity, and the electron transport
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chain (ETC) [5]. Defects in the OXPHOS system can cause a variety of cardiovascular diseases, such as
ischemic heart failure, and diabetic cardiomyopathies, in which cardiac mitochondrial dysfunction and
impaired energy production have been observed, potentially contributing to a decrease in contractile
function and cardiac efficiency [5–7].
Tissue-resident mesenchymal stem cells play an essential role in maintaining normal tissue
function under physiological and pathological conditions. Cardiac mesenchymal stem cells (C-MSC)
reside in the heart and express the early cardiac-specific transcription factor GATA4 and mesenchymal
stem cell markers, including CD105, CD140, and Sca-1 [8,9]. C-MSC transplantation improved heart
repair in ischemic myocardium via secretion of exosomes [8,10] and bioactive proteins such as VEGF
and SDF-1α [11]. However, little is known about the metabolism of C-MSC contained in adult hearts.
MicroRNAs (miRNAs) are small, noncoding RNAs (containing about 22 nucleotides) that function
in regulating gene expression, mostly at the posttranscriptional level [12]. Additionally, miRNAs have
been implicated in the regulation of energy metabolism in previous studies [13–15]. The biogenesis
of miRNAs is under tight regulatory control; in particular, an RNase III endoribonuclease, Dicer,
plays an indispensable role in cleaving pre-miRNAs into mature miRNAs that are loaded onto the
RNA-induced silencing complex (RISC) in the cytoplasm to exert their biological function [16]. Because
Dicer directly affects the final process of miRNA maturation, it is essential for maintaining normal heart
development [17], stem cell proliferation and differentiation [18,19], and normal cardiac function [20].
Dicer expression is essential for postnatal cardiac development and function [21]. Dicer expression was
reported to be reduced in end-stage human dilated cardiomyopathy and heart failure; conversely, Dicer
expression was reported to be increased in the hearts of patients with improved cardiac function after
implantation of left ventricle assist devices [20]. Alterations in cardiac metabolism are considered as a
critical feature in the pathophysiology of cardiac dysfunction, in which cardiac metabolism switches
from fatty acid oxidation to anaerobic glycolysis [5]. However, little is known about the role of Dicer in
regulating C-MSC metabolism. We hypothesized that down-regulation of Dicer expression in C-MSC
modulates cellular metabolism to accommodate diminished oxygen and substrate supply associated
with heart failure. In this study, we assessed the role of Dicer in the metabolism of adult mouse and
human C-MSC. We found that Dicer deletion significantly reduces mitochondrial respiration and
influences fatty acid β-oxidation by decreasing the expression of related enzymes in C-MSC.
2. Results
2.1. Characterization of C-MSC
C-MSC were grown from enzymatically digested adult mouse hearts and achieved approximately
80% confluence after 7–10 days in culture (Figure 1A). C-MSC express a significantly higher level of
cardiac-specific genes, such as GATA4, NK2 homeobox 5 (Nkx2.5), and cardiac troponin-I (cTnI) in
comparison with bone marrow-derived MSC (BM-MSC) by qRT-PCR (Figure 1B). Immunofluorescent
staining showed that C-MSC express GATA4, an early cardiac transcription factor (Figure 1C) [22],
indicative of their cardiac origin. Surface marker expression was profiled by flow cytometry. Over
60% of cells were positive for CD105, and 74% cells were positive for CD140b, whereas only 0.1%
were positive for CD31, and 0.5% for CD45 (Figure 1D). These data indicate that C-MSC represent a
subpopulation of cardiac-derived mesenchymal stem cells [23].
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Figure 1. Characterization of cardiac mesenchymal stem cells (C-MSC). (A) Cultured C-MSC, scale 
bar = 1000 μm. (B) Comparison of mRNA expression of GATA4, NK2 homeobox 5 (Nkx2.5), and 
cardiac troponin-I (cTnI), three cardiac-specific genes, between C-MSC and bone marrow-derived 
MSC (BM-MSC). The amount of mRNA was normalized using β-actin (n = 3, ** p < 0.01, *** p < 0.001). 
(C) Immunofluorescent staining of C-MSC for the cardiac transcription factor GATA4 (red), scale bar 
= 50 μm. (D) Flow cytometric analyses of C-MSC for expression of the cell surface markers CD140b, 
CD105, CD31, and CD45. 
2.2. Adenovirus-Mediated Cre recombinase enzyme (CRE) Deletion of Dicer in C-MSC 
To delete Dicer in C-MSC, floxed Dicer C-MSC were infected with adenovirus expressing CRE 
recombinase (Dicer -/-C-MSC); a GFP-expression adenovirus was employed as a control (DicerF/FC-
MSC). We determined whether infection of C-MSC with CRE recombinase resulted in a stable loss of 
Dicer mRNA and protein. As shown in Figure 2, infection with CRE recombinase resulted in the 
ablation of Dicer at both mRNA (Figure 2A) and protein (Figure 2B) levels. Cells infected with GFP 
or Cre recombinase were subsequently passaged for use in experiments. Immunofluorescent staining 
for Ki67 showed a twofold increase in Ki67 positive cells in the Dicer -/- C-MSC compared with Dicer 
F/F C-MSC (Figure 2C). Furthermore, we measured proliferating cell nuclear antigen (PCNA) and 
Phospho-H3 as mitotic markers by western blotting, as shown in Figure 2D, compared to Dicer floxed 
cells, and found that the knockout of Dicer in C-MSC increased the levels of both PCNA and P-H3 
expression, indicating that the Dicer knockout increased cell proliferation. Next, we used terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) to evaluate cell apoptosis, observing 
by immunostaining approximately two fold higher TUNEL-positive Dicer -/- C-MSC compared with 
DicerF/F C-MSC (Figure 2E), indicating that Dicer ablation in C-MSC led to increased cell apoptosis. 
Figure 1. Characterization of cardiac mesenchymal stem cells (C-MSC). (A) Cultured C-MSC, scale
bar = 1000 µm. (B) Comparison of mRNA expression of GATA4, NK2 homeobox 5 (Nkx2.5), and cardiac
troponin-I (cTnI), three cardiac-specific genes, between C-MSC and bone marrow-derived MSC
(BM-MSC). The amount of mRNA was normalized using β-actin (n = 3, ** p < 0.01, *** p < 0.001).
(C) Immunofluorescent staining of C-MSC for the cardiac transcription factor GATA4 (red), scale
bar = 50 µm. (D) Flow cytometric analyses of C-MSC for expression of the cell surface markers CD140b,
CD105, CD31, and CD45.
2.2. Adenovirus-Mediated Cre Recombinase Enzyme (CRE) Deletion of Dicer in C-MSC
To delete Dicer in C-MSC, floxed Dicer C-MSC were infected with adenovirus expressing
CRE recombinase (Dicer −/−C-MSC); a GFP-expression adenovirus was employed as a control
(DicerF/FC-MSC). We determined whether infection of C-MSC with CRE recombinase resulted in a
stable loss of Dicer mRNA and protein. As shown in Figure 2, infection with CRE recombinase resulted
in the ablation of Dicer at both mRNA (Figure 2A) and protein (Figure 2B) levels. Cells infected with
GFP or Cre recombinase were subsequently passaged for use in experiments. Immunofluorescent
staining for Ki67 showed a twofold increase in Ki67 positive cells in the Dicer −/− C-MSC compared
with Dicer F/F C-MSC (Figure 2C). Furthermore, we measured proliferating cell nuclear antigen (PCNA)
and Phospho-H3 as mitotic markers by western blotting, as shown in Figure 2D, compared to Dicer
floxed cells, and found that the knockout of Dicer in C-MSC increased the levels of both PCNA and
P-H3 expression, indicating that the Dicer knockout increased cell proliferation. Next, we used terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) to evaluate cell apoptosis, observing
by immunostaining approximately two fold higher TUNEL-positive Dicer −/− C-MSC compared with
DicerF/F C-MSC (Figure 2E), indicating that Dicer ablation in C-MSC led to increased cell apoptosis.
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Figure 2. Adenovirus-mediated CRE recombinase expression resulted in a loss of Dicer expression in 
C-MSC. (A) Relative expression of Dicer mRNA. The amount of mRNA was normalized using β-actin. 
Results are shown as mean with standard error of the mean (SEM) (n = 3). (B) Western blotting of 
Dicer protein in adenovirus GFP (Ad-GFP) treated Dicer F/F C-MSC (Dicer F/F), and adenovirus with 
CRE recombinase (Ad-CRE) treated Dicer F/F C-MSC (Dicer-/-) using β-actin as a loading control. (C) 
Comparison of the percentage of Ki67-positive cells between Dicer F/F and Dicer -/- C-MSC (scale bar= 
100 μm) (* p < 0.05, n = 6). (D) Western blotting of PCNA and Phospho-H3 expression in Dicer F/F C-
MSC (Dicer F/F), and Dicer -/- C-MSC (Dicer -/-) using β-actin as a loading control (** p < 0.01; *** p < 
0.001, n = 3). (E) Comparison of the percentage of TUNEL-positive cells between Dicer F/F and Dicer -/- 
C-MSC (scale bar= 100 um) (*, p < 0.05, n = 20). 
2.3. Dicer Deletion Impairs Mitochondrial Respiration in C-MSC 
To investigate whether the mitochondrial respiratory function in C-MSC is affected in response 
to Dicer gene deletion, we quantified cellular oxygen consumption rate (OCR), an index of oxidative 
phosphorylation. The injection of 1.25 μM oligomycin, 1 μM carbonylcyanide 4-(trifluoromethoxy)-
phenylhydrazone (FCCP), and 0.5 μM rotenone/antimycin A allowed us to evaluate the sources and 
contribution of both mitochondrial and non-mitochondrial oxygen consumption. Figure 3A shows 
the protocol and calculations that were made with the injection of each compound.  
Figure 2. Adenovirus-mediated CRE recombinase expression resulted in a loss of Dicer expression in
C-MSC. (A) Relative expression of Dicer mRNA. The amount of mRNA was normalized using β-actin.
Results are shown as mean with standard error of the mean (SEM) (n = 3). (B) Western blotting of
Dicer protein in adenovirus GFP (Ad-GFP) treated Dicer F/F C-MSC (Dicer F/F), and adenovirus with
CRE recombinase (Ad-CRE) treated Dicer F/F C-MSC (Dicer−/−) using β-actin as a loading control.
(C) Comparison of the percentage of Ki67-positive cells between Dicer F/F and Dicer −/− C-MSC (scale
bar = 100 µm) (* p < 0.05, n = 6). (D) Western blotting of PCNA and Phospho-H3 expression in Dicer
F/F C-MSC (Dicer F/F), and Dicer −/− C-MSC (Dicer −/−) using β-actin as a loading control (** p < 0.01;
*** p < 0.001, n = 3). (E) Comparison of the percentage of TUNEL-positive cells between Dicer F/F and
Dicer −/− C-MSC (scale bar= 100 um) (*, p < 0.05, n = 20).
2.3. Dicer Deletion Impairs Mitochondrial Respiration in C-MSC
To investigate whether the mitochondrial respiratory function in C-MSC is affected in response to
Dicer gene deletion, we quantified cellular oxygen consumption rate (OCR), an index of oxidative
phosphorylation. The injection of 1.25µM oligomycin, 1µM carbonylcyanide 4-(trifluoromethoxy)-
phenylhydrazone (FCCP), and 0.5µM rotenone/antimycin A allowed us to evaluate the sources and
contribution of both mitochondrial and non-mitochondrial oxygen consumption. Figure 3A shows the
protocol and calculations that were made with the injection of each compound.
As shown in Figure 3B, Dicer −/− C-MSC exhibited a lower OCR compared with Dicer F/F C-MSC.
Further calculation of the different components of oxygen consumption is shown in Figure 3C–J.
Basal respiration, maximal respiration, non-mitochondrial respiration, proton leak, ATP production,
and spare respiratory capacity were all significantly reduced in Dicer −/− C-MSC in comparison with
Dicer F/F C-MSC. However, the coupling efficiency was higher in Dicer −/− C-MSC in comparison with
Dicer F/F C-MSC. Taken together, these findings suggest that Dicer gene deletion results in decreased
mitochondrial oxidative phosphorylation.
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Figure 3. Assessment of oxygen consumption rate (OCR) in Dicer F/F and Dicer −/− C-MSC.
(A) Schematic representation of the protocol employed in data collection and calculations of
mitochondrial respiration. (B) Normalized OCR data. (C–J) Measurements of mitochondrial respiration
calculated from the OCR tracing in (B). Results are normalized to total cellular protein and shown
as mean ± SEM (n = 8), * p < 0.05. OM: Oligomycin; FCCP: carbonylcyanide 4-(trifluoromethoxy)-
phenylhydrazone; Rot/AA: Rotenone & antimycin A.
2.4. Dicer Gene Deletion Increases Glycolysis in C-MSC
Next, we quantified the extracellular acidification rate (ECAR), an index of cellular glycolytic
capacity, in C-MSC using an established protocol [24]. Figure 4A–C shows that the ablation of Dicer in
C-MSC increased basal and compensatory glycolysis compared to Dicer floxed C-MSC, suggesting
that Dicer gene deletion led to increased glycolytic capacity in C-MSC.
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Figure 4. Assessment of extracellular acidification rate (ECAR) in Dicer F/F and Dicer -/- C-MSC. (A) 
Normalized ECAR data. (B) Measurements of basal glycolysis and compensatory glycolysis from the 
ECAR tracing in (A). Results are normalized to total cellular protein and shown as mean with SEM (n 
= 8), * p < 0.05. 
2.5. Dicer Deletion Decreases Mitochondrial Fatty Acid β-Oxidation in C-MSC 
To further investigate the effect of Dicer deletion on fatty acid oxidative metabolism, we 
examined the expression of key fatty acid oxidation genes (Figure 5). Dicer -/- C-MSC exhibited 
decreased expression of genes related to fatty acid oxidation, such as sirtuin 1 (Sirt1), peroxisome 
proliferator-activated receptor gamma coactivator 1 beta (Ppargc1b), acetyl coenzyme A (acyl-CoA) 
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dehydrogenase (Ogdh), succinate dehydrogenase complex subunit (DSdhd), and ubiquinol-
cytochrome C reductase complex III subunit VII (Uqcrq)) was similar in Dicer F/F C-MSC and Dicer -/- 
C-MSC. These data suggest that Dicer plays an essential role in mitochondrial fatty acid oxidative 
metabolism by regulating genes that promote β-oxidation, but not oxidative phosphorylation, in C-
MSC. Down-regulation of fatty acid oxidation genes following Dicer ablation suggests that Dicer may 
function as a metabolic switch in C-MSC. To determine whether the down-regulation of the fatty acid 
oxidation genes in response to Dicer ablation is conserved between mouse and human-derived C-
MSC, we performed expression studies in Dicer small interfering RNA (siRNA)-treated human C-
MSC and control (scramble siRNA-treated human C-MSC) by qRT-PCR, as shown in Figure S1, and 
Dicer expression was found to be down-regulated by approximately 75% by siRNA transfection in 
human C-MSC. Both Sirt1 and Ppargc1b were significantly down-regulated, although we detected 
no changes in expression of Acox3 or Hadhb. These findings suggest that Dicer regulation of fatty 
acid oxidation genes is at least partially conserved in C-MSC. We further investigated the effect of 
Dicer knockout on the mitochondrial structure using mitotracker red and DAPI staining. Both Dicer 
floxed and knockout C-MSC exhibited a normally well-defined mitochondrial shape, and no 
remarkable change of mitochondrial mass detected by MitoTracker Red staining between Dicer F/F 
and Dicer -/- C-MSC (Figure 5B). To quantify the number of mitochondria between Dicer F/F and Dicer 
Figure 4. Assessment of extracellular acidification rate (ECAR) in Dicer F/F and Dicer −/− C-MSC.
(A) Normalized ECAR data. (B,C) Measurements of basal glycolysis and compensatory glycolysis from
the ECAR tracing in (A). Results are normalized to total cellular protein and shown as mean with SEM
(n = 8), * p < 0.05.
2.5. Dicer Deletion Decreases Mitochondrial Fatty Acid β-Oxidation in C-MSC
To further investigate the effect of Dicer deletion on fatty acid oxidative metabolism, we
examined the expression of key fatty acid oxidation genes (Figure 5). Dicer −/− C-MSC exhibited
decreased expression of genes r lated to fat id oxidation, such as sirtuin 1 (Sirt1), peroxisome
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proliferator-activated receptor gamma coactivator 1 beta (Ppargc1b), acetyl coenzyme A (acyl-CoA)
oxidase 3 (Acox3), and hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit
beta (Hadhb), compared to Dicer F/F C-MSC, although no differences in expression were detected for
acyl-CoA oxidase 1 (Acox1) and hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex
subunit alpha (Hadha). Expression of genes related to the TCA cycle and ETC (e.g., isocitrate
dehydrogenase (nicotinamide adenine dinucleotide (NAD)(+)) 3 Alpha (Idh3a), oxoglutarate
dehydrogenase (Ogdh), succinate dehydrogenase complex subunit (DSdhd), and ubiquinol-cytochrome
C reductase complex III subunit VII (Uqcrq)) was similar in Dicer F/F C-MSC and Dicer −/− C-MSC.
These data suggest that Dicer plays an essential role in mitochondrial fatty acid oxidative metabolism
by regulating genes that promote β-oxidation, but not oxidative phosphorylation, in C-MSC.
Down-regulation of fatty acid oxidation genes following Dicer ablation suggests that Dicer may
function as a metabolic switch in C-MSC. To determine whether the down-regulation of the fatty
acid oxidation genes in response to Dicer ablation is conserved between mouse and human-derived
C-MSC, we performed expression studies in Dicer small interfering RNA (siRNA)-treated human
C-MSC and control (scramble siRNA-treated human C-MSC) by qRT-PCR, as shown in Figure S1,
and Dicer expression was found to be down-regulated by approximately 75% by siRNA transfection in
human C-MSC. Both Sirt1 and Ppargc1b were significantly down-regulated, although we detected no
changes in expression of Acox3 or Hadhb. These findings suggest that Dicer regulation of fatty acid
oxidation genes is at least partially conserved in C-MSC. We further investigated the effect of Dicer
knockout on the mitochondrial structure using mitotracker red and DAPI staining. Both Dicer floxed
and knockout C-MSC exhibited a normally well-defined mitochondrial shape, and no remarkable
change of mitochondrial mass detected by MitoTracker Red staining between Dicer F/F and Dicer −/−
C-MSC (Figure 5B). To quantify the number of mitochondria between Dicer F/F and Dicer −/− C-MSC,
we extracted genomic DNA from C-MSC and measured relative mitochondrial and nuclear genome
copy numbers by qPCR, as shown in Figure 5C. Compared to Dicer F/F C-MSC, Dicer −/− C-MSC
exhibited approximately 28% reduced mitochondrial DNA content.
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3), NS p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001. (B) Representative MitoTracker Red CMXRos and 
DAPI staining of Dicer F/F and Dicer -/- C-MSC; confocal microscopy showed no remarkable change of 
mitochondrial mass detected by MitoTracker Red staining between Dicer F/F and Dicer -/- C-MSC 
(Scale bar= 50 µm). (C) Comparison of the relative amount of mitochondrially encoded 1,4-
Dihydronicotinamide adenine dinucleotide (NADH): ubiquinone oxidoreductase core subunit 6 (MT-
ND6) mitochondrial DNA (mtDNA) between Dicer F/F and Dicer -/- C-MSC. The amount of mtDNA 
was normalized to nuclear-encoded control gene DNA polymerase beta (PolB). (n = 4), * p < 0.05. 
3. Discussion 
In this study, we compared cellular metabolism and energetics in adult C-MSC following 
deletion of Dicer, a key enzyme involved in miRNA processing. Dicer gene deletion converted adult 
C-MSC from an oxidative state to a glycolytic state and selectively downregulated the expression of 
critical fatty acid oxidation genes, suggesting that Dicer functions as a metabolic switch in C-MSC.  
In our study, we demonstrated that knockout of Dicer in C-MSC increased the number of 
proliferating cells and protein levels of PCNA and p-H3, the markers of cell mitosis, in C-MSC 
compared to Dicer floxed cells, suggesting that Dicer knockout increased cell proliferation. 
Meanwhile, knockout of Dicer increased apoptosis occurred, as shown by TUNEL analysis. As we 
have seen, although Dicer knockout increased apoptosis, most Dicer knockout cells (>96%) survived, 
whereas viable cells in Dicer floxed group were approximately 98%. Overall, our data suggested that 
Dicer knockout can lead to concurrent increase in both cell proliferation and apoptosis. Similar 
findings were reported by Zhang L et al. [25], who found that Dicer ablation induced an increase in 
prostate cell apoptosis, and, paradoxically, the proliferation of epithelial cells in Dicer knockout mice 
increased by about three fold, which the authors believe was due to at least in part its compensatory 
growth.  
Oxidation of fatty acids in the mitochondria is an indispensable physiological process in 
eukaryotes, including humans. After entering the mitochondria, fatty acids are completely oxidized 
to water and carbon dioxide through β-oxidation, the TCA cycle, and the ETC [26]. The TCA cycle 
Figure 5. (A) Comparison of relative mRNA le ls of genes r la ed t mitochondrial fatty acid
oxidation in mouse Dicer F/F and Dicer −/− C-MSC. The amount of mRNA was normalized using
β-actin. TCA, tricarboxylic acid cycle; ETC, electron transport chain. Results are shown as mean
± SEM (n = 3), NS p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001. (B) Representative MitoTracker
Red CMXRos and DAPI taining of Dicer F/F and Dicer −/− C-MSC; confocal mi roscopy showed no
remarkable change of mitochondrial mass detected by Mit Tracker Red staining between Dicer F/F
and Dicer −/− C-MSC (Scale bar = 50 µm). (C) Comparison of the relative amount of mitochondrially
encoded 1,4-Dihydronicotinamide adenine dinucleotide (NADH): ubiquinone oxidoreductase core subunit
6 (MT-ND6) mitochondrial DNA (mtDNA) between Dicer F/F and Dicer −/− C-MSC. The amount of
mtDNA was normalized to nuclear-encoded control gene DNA polymerase beta (PolB). (n = 4), * p < 0.05.
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3. Discussion
In this study, we compared cellular metabolism and energetics in adult C-MSC following deletion
of Dicer, a key enzyme involved in miRNA processing. Dicer gene deletion converted adult C-MSC
from an oxidative state to a glycolytic state and selectively downregulated the expression of critical
fatty acid oxidation genes, suggesting that Dicer functions as a metabolic switch in C-MSC.
In our study, we demonstrated that knockout of Dicer in C-MSC increased the number of
proliferating cells and protein levels of PCNA and p-H3, the markers of cell mitosis, in C-MSC
compared to Dicer floxed cells, suggesting that Dicer knockout increased cell proliferation. Meanwhile,
knockout of Dicer increased apoptosis occurred, as shown by TUNEL analysis. As we have seen,
although Dicer knockout increased apoptosis, most Dicer knockout cells (>96%) survived, whereas
viable cells in Dicer floxed group were approximately 98%. Overall, our data suggested that Dicer
knockout can lead to concurrent increase in both cell proliferation and apoptosis. Similar findings
were reported by Zhang L et al. [25], who found that Dicer ablation induced an increase in prostate cell
apoptosis, and, paradoxically, the proliferation of epithelial cells in Dicer knockout mice increased by
about three fold, which the authors believe was due to at least in part its compensatory growth.
Oxidation of fatty acids in the mitochondria is an indispensable physiological process in eukaryotes,
including humans. After entering the mitochondria, fatty acids are completely oxidized to water
and carbon dioxide through β-oxidation, the TCA cycle, and the ETC [26]. The TCA cycle and ETC
also participate in the oxidative metabolism of carbohydrates and proteins [27]. Although the role
of Dicer in regulating cellular metabolism of adult C-MSC is largely unknown, Dicer was reported
to coordinately regulate lipid metabolism and inflammatory responses in cardiac macrophages by
enhancing fatty acid-fueled mitochondrial respiration. Moreover, Dicer gene deletion decreased fatty
acid oxidation by modulating β-oxidation, the TCA cycle, and ETC activity in macrophages [28].
We found that Dicer gene deletion in C-MSC resulted in a significant reduction in mitochondrial
oxidative metabolism, and increased glycolysis; thus, Dicer appears to be important in maintaining
fatty acid oxidative metabolism/β-oxidation in C-MSC.
To investigate the mechanism by which Dicer gene deletion represses mitochondrial oxidative
metabolism in C-MSC, we analyzed the expression of β-oxidation, TCA, and ETC-related genes
in C-MSC with/without Dicer knockout. We found that Dicer gene deletion significantly reduced
the expression of Sirt1, Ppargc1b, Acox3, and Hadhb, without affecting the expression of TCA and
ETC-related genes. Ppargc1 is preferentially expressed in tissues with high oxidative capacities, such as
heart and brown adipose tissue, and serves as a regulator of mitochondrial function and cellular energy
metabolism [29]. Sirt1 deacetylase can increase oxidation rates of fatty acids by the deacetylation and
activation of transcriptional coactivator Ppargc1 [30,31]. Acox1, the first enzyme in the β-oxidation
pathway, catalyzes the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs [32]. Although Dicer gene
deletion in C-MSC did not reduce Acox1 expression, it significantly decreased Acox3 expression in
these cells. As a paralog of Acox1, Acox3 contributes significantly to peroxisomal branched-chain fatty
acid beta-oxidation [33]. Hadha and Hadhb respectively encode the alpha and beta subunits of the
mitochondrial trifunctional protein, which catalyzes the last three steps of mitochondrial beta-oxidation
of long-chain fatty acids [34]. Our data indicate that Dicer gene deletion significantly reduces Hadhb,
but not Hadha, expression. A recent study demonstrated that Hadhb is directly associated with
severe childhood-onset cardiomyopathies [35]. To determine whether similar gene-specific changes
would occur in human cells, we knocked down Dicer in human C-MSC (isolated from the right atrial
appendage). We achieved approximately 75% reduction in Dicer gene expression in these cells, which
resulted in significant downregulation of Sirt1 and Ppargc1, indicating that Dicer also regulates the
expression of fatty acid oxidation genes in human C-MSC. On the basis of the concept that Dicer
controls the maturation of thousands of small non-coding RNAs, one mRNA can also be targeted
by multiple miRNAs. Therefore, the metabolic switch induced by Dicer gene deletion might not be
explained by single aberrant miRNA controlling expression of fatty acid oxidation genes in C-MSC, but
rather by perturbation of an interaction-regulatory network controlled by thousands of miRNAs [36].
Int. J. Mol. Sci. 2019, 20, 5554 8 of 14
The fetal heart exists in a hypoxic environment and obtains the bulk of its energy via glycolysis.
After birth, the “fetal switch” to the oxidative metabolism of glucose and fatty acids has been linked to the
loss of the regenerative phenotype [37]. Our study suggests that Dicer-intact C-MSC rely on oxidative
metabolism, whereas knocking out Dicer increases glycolysis and inhibits mitochondrial oxidative
metabolism, suggesting that Dicer −/− C-MSC can adapt to a low fatty acid environment. Embryonic
stem cells, as well as cancer cells, exhibit high glycolysis rates, and low oxidative phosphorylation
to support rapid cell proliferation, irrespective of oxygen tension, a phenomenon known as the
Warburg effect [38]. The primary function of aerobic glycolysis is to provide glycolytic intermediates
for anabolic reactions in these cells, thereby becoming a metabolic pathway of choice during cell
proliferation [39,40].
Our study provides evidence that Dicer gene deletion in C-MSC converts cellular metabolism
from an oxidative state to a glycolytic state. We anticipate that the decrease in Dicer expression in
C-MSC may make C-MSC more adaptable to ischemic myocardium by reducing energy expenditure.
Although we observed increased cell proliferation and apoptosis in Dicer knockout C-MSC, we cannot
exclude the possibility that transient knockdown of Dicer in donor adult stem cells might improve
donor cell survival in ischemic myocardium after cell transplantation. In vivo experiments are needed
to test this hypothesis.
4. Materials and Methods
4.1. Isolation of Mouse and Human C-MSC
Dicer floxed mice (The Jackson Laboratory, Bar Harbor, ME, USA) were euthanized, and hearts
were harvested and washed with 1× phosphate-buffered saline (PBS). Mouse C-MSC were isolated
from these hearts, as previously described [8,9,41], and used at passage 6–10. Human right atrial
appendage tissues were collected from patients undergoing cardiothoracic surgery. The collection of
discarded right atrial appendages was approved by the Institutional Review Board of Medical College
of Georgia at Augusta University. The study was based on the recommendations of the Declaration of
Helsinki. Tissues were minced into approximately 1 mm three-sized pieces and digested using 0.1%
collagenase IV and 1 U/mL dispase in. Dulbecco’s Modified Eagle Medium F-12 (DMEM/F-12) for
1 h at 37 ◦C. Then, cardiac explants were collected and incubated on fibronectin/gelatin-coated plates
(0.5 mg fibronectin in 100 mL 0.1% gelatin) in DMEM containing 10% fetal bovine serum, 100 U/mL
penicillin G, and 100 µg/mL streptomycin. Cells were cultured under these conditions until they
became confluent in 7–10 days.
4.2. siRNA Transfection
Human C-MSC in 24-well plates were incubated with 20 nM of human Dicer small interfering
RNA (siRNA) or scrambled negative control (NC) siRNA (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) with Lipofectamine RNAiMax transfection reagent (Thermo Fisher, Waltham, MA, USA) in 1 mL
culture medium for 48 h at 37 ◦C.
4.3. Flow Cytometry
C-MSC were blocked with 5% rat serum and stained respectively with conjugated antibodies,
including anti-CD105-APC (BioLegend, San Diego, CA, USA), anti-CD31-APC (BD Biosciences, San Jose,
CA, USA), anti-CD45-APC (BD Biosciences), anti-CD140b-PE (BioLegend), or isotype-matched control
antibody (BD Biosciences). Flow cytometry analysis of cultured C-MSC was performed with a BD
LSRII flow cytometer and BD FACSDiva™ software (8.02, BD Biosciences, San Jose, CA, USA).
4.4. Immunofluorescent Staining
For cell staining, C-MSC plated on an 8-well chamber slide (Thermo Fisher Scientific, Waltham,
MA, USA) were fixed with 4% paraformaldehyde, followed by the permeabilization with 1% TritonTM
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X-100. After blocking with 5% goat serum, cells were incubated with rabbit anti-GATA4 (1:100;
Aviva System Biology, San Diego, CA, USA) or anti-Ki67 (1:400, Cell Signaling Technology, Danvers,
MA, USA) at 4 ◦C overnight. Secondary antibody incubation with goat anti-rabbit Alexa Fluor
555-conjugated (1:400, Invitrogen, Carlsbad, CA, USA) was performed the following day. To detect cell
apoptosis, we performed TUNEL staining using DEAD End TUNEL kit (Promega, Madison, WI, USA)
according to the manufacturer’s instructions with modifications [41,42]. Briefly, cells were fixed with
4% paraformaldehyde and permeabilized with 1% Triton X-100. Labeling reactions were performed
for 60 min at 37 ◦C, followed by streptavidin Alexa Fluor 555-conjugated (1:400, Life Technologies,
Carlsbad, CA, USA) incubation. Slides were mounted using VECTASHIELD HardSet Mounting
Medium with DAPI (Vector Laboratories, Burlingame, CA, USA). Staining was analyzed by a Zeiss
780 laser scanning microscope (Carl Zeiss, Thornwood, NY, USA). The number of Ki67-positive or
TUNEL-positive cells were counted in six randomly selected fields.
For mitochondrial staining, C-MSC in 3.5 cm glass-bottom microwell dishes (MatTek, Ashland,
MA) were incubated with DMEM containing 100 nM Mitotracker Red CMXRos (Invitrogen, Carlsbad,
CA, USA) at 37 ◦C for 15 min. After fixing with 4% paraformaldehyde, cells were mounted with
VECTASHIELD HardSet Mounting Medium with DAPI. Staining was analyzed by a Zeiss 780 laser
scanning microscope (Carl Zeiss, Thornwood, NY, USA).
4.5. Plasmid Construct and Generation of Recombinant Adenoviruses
The adeno-backbone plasmid (pAdtrack-CMV-CRE) was produced by amplifying 1 kb of
CRE cDNA from Puro.Cre plasmid (a gift from Tyler Jacks, Addgene plasmid #17408) via PCR
with primers containing Not1 and Xho1 restriction sites on the ends (Forward PCR primer:
5′-AAGGAAAAAAGCGGCCGCGCCACCATGCCCAAGAAGAAGAGGAA-3′. Reverse PCR primer:
5′-CTAGCTCGAGCTAATCGCCATCTTCCAGCA-3′). The CRE fragment was subcloned into the
Not1-Xho1 site of the pAdtrack-CMV vector (a gift from Bert Vogelstein, Addgene plasmid #16405).
Recombinant adenovirus Adtrack-CMV-CRE and Adtrack-CMV were generated by using the AdEasy-1
expression system, as previously described [43]. Briefly, parental empty pAdtrack-CMV bearing GFP
and pAdtrack-CMV-CRE vectors bearing CRE and GFP were first linearized with PmeI and then
introduced into BJ5183-AD-1 electroporation competent cells (Agilent Technologies, La Jolla, CA) by
electroporation. Recombinant adenoviral plasmids were recovered from E. coli and introduced into
AD-293 cells by Fugene HD (Roche Applied Science, Indianapolis, IN, USA). The recombinant viruses
were propagated in AD-293 cells, purified, and concentrated using the Adeno MINI Purification ViraKit
(VIRAPUR, LLC, San Diego, CA, USA). Floxed Dicer C-MSC seeded on dishes were infected with
adenoviruses at a multiplicity of infection of 200 for the described experiments.
4.6. Isolation and Quantification of Genomic DNA and Messenger RNA
Genomic DNA was extracted from C-MSC with the QIAamp DNA blood mini kit (QIAGEN,
Valencia, CA) following the manufacturer’s instructions.
Total RNA was extracted by RNAzol RT (Molecular Research Center, Inc, Cincinnati, OH, USA)
following the manufacturer’s instructions. cDNA was synthesized from total RNA using the RevertAid
First Strand cDNA Synthesis kit (Thermo Scientific). The cDNA was used to perform quantitative
PCR on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA)
using PowerUp SYBR Green Master Mix (Thermo Fisher, Waltham, MA, USA). Amplification was
performed at 50 ◦C for 2 min, 95 ◦C for 2 min, followed by 50 cycles of 95 ◦C for 15 s, and 60 ◦C for
1 min. The primer sequences are listed in Table 1.
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Table 1. Primer list.
Gene Sequence (5′–3′)
β-actin FWD (mouse) AGAGCATAGCCCTCGTAGAT
β-actin REV (mouse) GCTGTGCTGTCCCTGTATG
Dicer FWD (mouse) TTACCAGCGCTTAGAATTCCTGGG
Dicer REV (mouse) GTTATTGACAAGGGCAGAGCGCAA
Sirt1 FWD (mouse) GTTGGTGGCAACTCTGATAAATG
Sirt1 REV (mouse) GTCATAGGCTAGGTGGTGAATATG
Ppargc1b FWD (mouse) AGGTGTGAGGGAAGCATAGA
Ppargc1b REV (mouse) CAAAGCCTTCTGGACTGAGTT
Acox1 FWD (mouse) CCTTGGCCAATGCTCTCATTA
Acox1 REV (mouse) CGCAGCAGTATAAACTCTTCCC
Acox3 FWD (mouse) CCCTAGAGAAGCTACGAGAACT
Acox3 REV (mouse) CAGGCAGTTAATCAGCACTAGAA
Hadha FWD (mouse) CCATGTCGGCCTTCTCAAA
Hadha REV (mouse) AGTGAAGAAGAAAGCTCTCACAT
Hadhb FWD (mouse) AGACCATGGGCCACTCT
Hadhb REV (mouse) CTTCTTGGCCAGACTATGAGAAC
Idh3a FWD (mouse) GGCCATCCATCTATGAATCTGT
Idh3a REV (mouse) GTATTCTCCTTCCGTGTTCTCTC
Ogdh FWD (mouse) CATGTATCACCGCAGGATCAA
Ogdh REV (mouse) GGTCTTTCCCATCACGACAG
Sdhd FWD (mouse) GATGCCGACATCGTGGTAAT
Sdhd REV (mouse) GTTACCGACTACGTTCATGGG
Uqcrq FWD (mouse) CTTTGCTGAAATAGCTTGGGAAG
Uqcrq REV (mouse) GAACCTGGCGCGGATAC
GATA4 FWD (mouse) GAGGGTGAGCCTGTATGTAATG
GATA4 REV (mouse) CCTGCTGGCGTCTTAGATTTAT
NKX2-5 FWD (mouse) GCAGTGGAGCTGGACAAA
NKX2-5 REV (mouse) GGTACCGCTGTTGCTTGA
cTNI FWD (mouse) CACCTCAAGCAGGTGAAGAA
cTNI REV (mouse) GCCACTCAGTGCATCGATATT
MT-ND6 FWD (mouse) CACCCAGCTACTACCATCATTC
MT-ND6 REV (mouse) GTTTGGGAGATTGGTTGATGTATG
POLB FWD (mouse) GGCGGATGGTGTACTCATT
POLB REV (mouse) ACTGTGGTGTTCTCTACTTCAC
β-actin FWD (human) CGTAGCACAGCTTCTCCTTAAT
β-actin REV (human) GGACCTGACTGACTACCTCAT
Dicer FWD (human) GGTTCCAGAACTCTGTGCTATAC
Dicer REV (human) AGGCAGTGAAGGCGATAAAG
Sirt1 FWD (human) CACCCACACCTCTTCATGTT
Sirt1 REV (human) CATTACTCTTAGCTGCTTGGTCTA
Ppargc1b FWD (human) GGTAAGGATCGCAGCTTCAC
Ppargc1b REV (human) CCTCTTCCTCCTCCTCTTCTT
Acox3 FWD (human) CCCACAGAGGAGGAGGAAATA
Acox3 REV (human) GCGACTTGGAGAAATGGTCTAA
Hadhb FWD (human) CCAAGAAGGCACAGGATGAA
Hadhb REV (human) GGAAGGACGGATGCCATTAT
4.7. Western Blotting Assay
Western blotting was performed as described previously [8]. Briefly, normalized concentration
protein was loaded on a 10% SDS–polyacrylamide gel and separated by electrophoresis. Then, the protein
was transferred from the gel to a polyvinylidene difluoride (PVDF) membrane. After blocking with
Odyssey blocking buffer (LI-COR Biosciences, Lincoln, NE, USA), the membrane was probed using
rabbit anti-Dicer (1:2000, Novus Biologicals, Littleton, CO, USA), rabbit anti-PCNA (1:1000, Cell
signaling Technology), rabbit anti-phospho-Histone H3 (1:1000, Cell Signaling Technology), and mouse
anti-β Actin (1:5000, Novus Biologicals, Lincoln, NE, USA) at 4 ◦C overnight. After washing with
1 × TBST, the membrane was incubated for 1 h at room temperature with IRDye 680 goat anti-rabbit
IgG or IRDye 800 goat anti-mouse IgG (1:10,000, LI-COR Biosciences). The probed blot was scanned
using an Odyssey infrared imager.
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4.8. Seahorse Analysis of Mitochondrial Respirometry
OCR and ECAR were detected using Seahorse XF 96 Extracellular Flux Analyzer (Agilent
Technologies, Lexington, MA, USA) according to the manufacturer’s instructions. Briefly, the cells
were plated at 10,000 cells/well in the Seahorse XF Cell Culture Microplate. The sensor cartridge for XF
analyzer was hydrated in a 37 ◦C non-CO2 incubator the day prior to experimentation. On the day of
the Seahorse assay, the medium was changed to Seahorse XF DMEM base medium, without phenol red,
supplemented with 10 mM glucose, 2 mM L-glutamine, and 1 mM pyruvate, pH 7.4, and then metabolic
parameters were measured using the Mitochondrial Stress Test Kit (Agilent, Cat. No. 103015-100,
Santa Clara, CA, USA). OCR and ECAR were performed using the following protocol after calibration
and equilibration: three cycles of wait 3 min, mix 3 min, measure 3 min basal values and then values
after each of the following injections (see Figure 3A for a description): 1.25µM oligomycin (final
concentration), 1µM FCCP (final), and 0.5µM rotenone/antimycin A (final). Post assay wells were
washed, lysed, and a bicinchoninic acid assay (BCA) Protein assay was performed for protein content.
Data presented are normalized for total protein per well. Each point represents an average of eight
different wells.
4.9. Statistics
Results are presented as the mean ± standard error of the mean (SEM). Unpaired Student’s t-test
was used to compare two groups. A value of p < 0.05 was considered statistically significant. Statistical
analyses were conducted with GraphPad Prism 7.0 software.
5. Conclusions
Our findings demonstrate an essential function of Dicer to maintain mitochondrial β-oxidation of
fatty acids in C-MSC. Dicer gene deletion in C-MSC switched the cellular metabolism from oxidative
state to a glycolytic state, likely in part by regulating the expression of essential genes involved in fatty
acid beta-oxidation.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/22/
5554/s1.
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Abbreviations
BM-MSC Bone marrow mesenchymal stem cells
Nkx2.5 NK2 homeobox 5
cTNI Cardiac troponin-I
MT-ND6 mitochondrially encoded NADH: ubiquinone oxidoreductase core subunit 6
POLB DNA polymerase beta
TUNEL Terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling
TCA Tricarboxylic acid
ETC Electron transport chain
C-MSC Cardiac mesenchymal stem cells
miRNAs microRNAs
OCR Oxygen consumption rate
ECAR Extracellular acidification rate
Sirt1 Sirtuin 1
Ppargc1b Peroxisome proliferator-activated receptor gamma coactivator 1 beta
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Acox1 Acyl-CoA oxidase 1
Acox3 Acyl-CoA oxidase 3
Hadha Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
Hadhb Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
Idh3a Isocitrate dehydrogenase (NAD(+)) 3 alpha
Ogdh Oxoglutarate dehydrogenase
Sdhd Succinate dehydrogenase complex subunit D
Uqcrq Ubiquinol-cytochrome C reductase complex III subunit VII
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